Future Planet Capital Acquires £2.7M+ from 412 Investors via Seedrs

Future Planet Capital, an impact-led, global VC company launched to invest in high-growth firms the world’s leading universities and research centers, has raised 111% (£2,777,247) of its  £2,500,065 target from 412 investors (at the time of writing) via Seedrs with 24 days left in its crowdfunding campaign.

As a “first-mover” in the impact investing space, Future Planet Capital has reportedly invested more than $300M into 100+ startups and spinouts “seeking to profitably solve the world’s greatest challenges in Climate Change, Education, Health, Sustainable Growth & Security.”

Incorporated in April 2017, the company has offices in George Town, Cayman Islands. It operates in the Finance & Payments sectors. It offers services that are mixed digital/non-digital and for the B2B/B2C market.

As noted in the update, Future Planet Capital reports a £37.2M pre-money valuation, a £81 share price, 6.94% equity offered, Type Equity, Tax relief N/A.

Here are the Business Highlights shared by the firm:

• 15x revenue growth with $6.5M TTM
• Successfully acquired 3 other VCs reaching $300M+ in assets
• Investors in Vaccitech (NASDAQ), 23andMe (NASDAQ) and more
• Over 100 portfolio companies invested in across 10 funds

The key features of the platform include a Secondary Market;  Seedrs nominee min. £81.00 +.

As mentioned in the update, Future Planet is the impact-led, global venture capital firm built to invest in high-growth companies. Established by Douglas Hansen-Luke in 2015, with a track record investing across emerging asset classes for 30 years, FPC is “one of the only venture groups in the world to benchmark impactful growth-stage companies emerging from the founders and science of the world’s top ten centres of innovation.”

This origination network “creates a rich pipeline of mission-aligned entrepreneurs with game-changing innovations.” The announcement also mentioned that to date, their impact investment thesis has seen them “back Vaccitech, the company that’s now listed on NASDAQ having supplied 1bn COVID-19 doses worldwide; Guideline, among Americas fastest-growing pension providers; 23andMe, who recently completed a $3.5BN IPO; Tokamak, a world leader in the race to Fusion Energy and Aria, revolutionizing AI drug discovery.”

The company further noted that they were also the first institutional venture capital firm to “open our business to the crowd.” Now, they return to Seedrs “having grown 10x+ in the last year, and have reserved 10% of this round for the crowd, as part of our commitment to democratize venture.”

Here’s the Monetization strategy shared by the company:

Three revenue streams combine to provide a strong diversified business:

• Venture Funds: The firm manages more than $300m in AUM across “over 10 different venture funds, where we take on average a 2% fixed management fee, contracted for between 5-10+ years.” Via acquisition and organic growth, their 5-year target is to “grow this to $1-2Bn of Venture Assets.” They also “charge a 20% performance fee on these funds, of which 40% is retained by the company and the rest to our management team to ensure long-term alignment and commitment.” Further, they are “often investing a GP commitment, on which we expect a return.”
• Co-investment Platform: Large investors “want access to our dealflow and the ability to invest alongside [them].” Their platform “provides a steady flow of unique co-investment opportunities and pre-emption allocations, for which [they] charge management & performance fees.” Their co-investors to date “have included large royal family offices, corporates and institutions.”
• Introducer and Sub Advisory Business: They have “signed partnerships to introduce deals to some of the largest private banks and corporations;” [they] take introductory and management fees for specific mandates and deals that we have originated.”